tiprankstipranks
Advertisement
Advertisement
Xeltis Showcases aXess Trial Progress in Hemodialysis Vascular Access
PremiumPrivate CompaniesXeltis Showcases aXess Trial Progress in Hemodialysis Vascular Access
20d ago
Xeltis Showcases aXess Vascular Access Technology in Kidney Care Webinar
Premium
Private Companies
Xeltis Showcases aXess Vascular Access Technology in Kidney Care Webinar
22d ago
Xeltis – Weekly Recap
Premium
Private Companies
Xeltis – Weekly Recap
26d ago
Xeltis Builds Clinical Momentum and Commercial Bench Strength Around aXess Hemodialysis Conduit
PremiumPrivate CompaniesXeltis Builds Clinical Momentum and Commercial Bench Strength Around aXess Hemodialysis Conduit
1M ago
Xeltis Highlights Pivotal aXess Data and Clinical Engagement at VASA 2026
Premium
Private Companies
Xeltis Highlights Pivotal aXess Data and Clinical Engagement at VASA 2026
1M ago
Clinical Data and U.S. Program Activity Highlight Progress for Xeltis aXess
Premium
Private Companies
Clinical Data and U.S. Program Activity Highlight Progress for Xeltis aXess
1M ago
Xeltis Steps Up Clinical Spotlight on aXess With Dual Kidney Disease Forum Push
PremiumPrivate CompaniesXeltis Steps Up Clinical Spotlight on aXess With Dual Kidney Disease Forum Push
2M ago
Xeltis Highlights Clinical Progress of aXess at Upcoming VASA 2026 Symposium
Premium
Private Companies
Xeltis Highlights Clinical Progress of aXess at Upcoming VASA 2026 Symposium
2M ago
Xeltis Showcases aXess Clinical Progress at 2026 VASA Dialysis Symposium
Premium
Private Companies
Xeltis Showcases aXess Clinical Progress at 2026 VASA Dialysis Symposium
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100